Transforming Formulation Development: Software Solutions for Microstructure-Guided Performance Assessment

Microstructure CQAs
Full field-of-view pharmaceutical tablet microstructure image showing internal phase distribution and pore network

Transforming Formulation Development: Software Solutions for Microstructure-Guided Performance Assessment

Conventional release modeling approaches often fall short when it comes to capturing the true physical complexities of drug release. Join digiM for an exclusive webinar exploring the latest software advancements in microstructure-informed mechanistic modeling. Developed over years of supporting all stages of drug product development across all major dosage forms, our commercially available software solutions bridge the gap between formulation design and real-world performance.

During this session, we will showcase how high-precision, microstructure-based simulations accurately capture drug release mechanisms in a way that eludes traditional methods. We will feature live demonstrations of our physics-based software solutions, dissoLab and ivisLab, showing exactly how they can accelerate formulation development and enable data-driven performance assessments. Through real-world case studies, attendees will see firsthand how to predict release performance for both complex long-acting systems and IR oral solid dosage forms. Whether you are working on advanced long-acting or standard oral solids, join us to discover how to leverage next-generation software to optimize your formulation process.

What You Will Learn

By attending this webinar, you will gain insights into the transition from traditional modeling to high-precision, physics-based simulations. Key takeaways include:

  • Microstructure-Informed Mechanistic Modeling: Learn how high-precision simulations use the actual microstructure of a drug product to predict real-world performance.
  • Software Demonstrations: See live walkthroughs of dissoLab and ivisLab to understand how these tools accelerate formulation development and enable data-driven assessments.
  • Application Across Dosage Forms: Discover how to apply these simulation techniques to both Immediate Release (IR) oral solid dosage forms and complex long-acting systems.
  • Practical Case Studies: Examine real-world examples of how microstructure-based simulations bridge the gap between initial formulation design and actual release performance.
  • Optimization Strategies: Learn how to leverage next-generation software to streamline your formulation process and reduce the need for iterative trial-and-error batching.

For additional information, learn more about our software solutions below:

  • dissoLab: This platform revolutionizes dissolution modeling by using real-world 2D and 3D images to track full surface area evolution on a per-pixel basis, allowing for accurate predictions of particle dissolution long before a physical batch is synthesized.
  • ivisLab: Specifically engineered for long-acting injectables and implants, ivisLab utilizes first-principles physics and microstructure-informed models to simulate complex drug release profiles in minutes, significantly reducing the need for costly and time-consuming in vitro lab testing.

AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo
AbbVie logo
AbbVie logo
Bausch Health logo
Bausch Health logo
Bristol Myers Squibb logo
Bristol Myers Squibb logo
Merck logo
Merck logo
Moderna logo
Moderna logo
Novartis logo
Novartis logo
Pfizer logo
Pfizer logo
Johnson & Johnson Innovative Medicine logo
Johnson & Johnson Innovative Medicine logo
Roche logo
Roche logo
Mirati Therapeutics logo
Mirati Therapeutics logo
Genentech logo
Genentech logo
Lonza logo
Lonza logo

Transform Your Program with Microstructure Science

Get started with a drug product digital twin.

Purple tablet dispersing into a fine particle cloud, illustrating drug microstructure disintegration